SUPREP BOWEL PREP KIT Drug Patent Profile
✉ Email this page to a colleague
When do Suprep Bowel Prep Kit patents expire, and what generic alternatives are available?
Suprep Bowel Prep Kit is a drug marketed by Braintree Labs and is included in one NDA.
The generic ingredient in SUPREP BOWEL PREP KIT is magnesium sulfate; potassium sulfate; sodium sulfate. There are one hundred and forty-six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the magnesium sulfate; potassium sulfate; sodium sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Suprep Bowel Prep Kit
A generic version of SUPREP BOWEL PREP KIT was approved as magnesium sulfate; potassium sulfate; sodium sulfate by TARO on March 19th, 2024.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SUPREP BOWEL PREP KIT?
- What are the global sales for SUPREP BOWEL PREP KIT?
- What is Average Wholesale Price for SUPREP BOWEL PREP KIT?
Summary for SUPREP BOWEL PREP KIT
![SUPREP BOWEL PREP KIT drug patent expirations Drug patent expirations by year for SUPREP BOWEL PREP KIT](/p/graph/s/t/SUPREP_BOWEL_PREP_KIT-patent-expirations.png)
![Drug Prices for SUPREP BOWEL PREP KIT](/p/graph/drug-price/SUPREP+BOWEL+PREP+KIT.png)
Recent Clinical Trials for SUPREP BOWEL PREP KIT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Virginia | N/A |
Seoul National University Hospital | Phase 4 |
Pharmbio Korea Co., Ltd. | Phase 4 |
Pharmacology for SUPREP BOWEL PREP KIT
Paragraph IV (Patent) Challenges for SUPREP BOWEL PREP KIT
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SUPREP BOWEL PREP KIT | Oral Solution | magnesium sulfate; potassium sulfate; sodium sulfate | 17.5 g/3.13 g/1.6 g | 022372 | 1 | 2010-11-08 |
US Patents and Regulatory Information for SUPREP BOWEL PREP KIT
SUPREP BOWEL PREP KIT is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting SUPREP BOWEL PREP KIT
FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY IN PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER
Exclusivity Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Braintree Labs | SUPREP BOWEL PREP KIT | magnesium sulfate; potassium sulfate; sodium sulfate | SOLUTION;ORAL | 022372-001 | Aug 5, 2010 | AA | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SUPREP BOWEL PREP KIT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Braintree Labs | SUPREP BOWEL PREP KIT | magnesium sulfate; potassium sulfate; sodium sulfate | SOLUTION;ORAL | 022372-001 | Aug 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SUPREP BOWEL PREP KIT
See the table below for patents covering SUPREP BOWEL PREP KIT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 528011 | ⤷ Sign Up | |
Slovenia | 2292244 | ⤷ Sign Up | |
Slovenia | 2233147 | ⤷ Sign Up | |
Denmark | 1499331 | ⤷ Sign Up | |
Cyprus | 1110011 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SUPREP BOWEL PREP KIT
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0124495 | SPC/GB01/006 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727 |
0984957 | CR 2012 00035 | Denmark | ⤷ Sign Up | PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105 |
1499331 | SPC/GB13/034 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: IZINOVA CONCENTRATE FOR ORAL SOLUTION. THE ACTIVE SUBSTANCE IS A MIXTURE OF 3 SALTS:SODIUM SULPHATE ANHYDROUS, MAGNESIUM SULPHATE HEPTAHYDRATE AND POTASSIUM SULPHATE.; REGISTERED: BE BE434323 20130220; UK PL34926/0016 20130313 |
0984957 | C300517 | Netherlands | ⤷ Sign Up | PRODUCT NAME: ACETYLSALICYLZUUR EN ESOMEPRAZOLMAGNESIUMTRIHYDRAAT; NAT. REGISTRATION NO/DATE: RVG 107516 20110912; FIRST REGISTRATION: 540235954023675402375 2011120812 |
1499331 | 13C0055 | France | ⤷ Sign Up | PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: BE - 434323 20130220 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |